(FM) Inmunología
Departamento académico
Hospital Costa Del Sol
Marbella, EspañaPublicaciones en colaboración con investigadores/as de Hospital Costa Del Sol (11)
2024
-
Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain
AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314
2023
-
Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019–2021
Journal of Medical Virology, Vol. 95, Núm. 12
2022
-
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 28, Núm. 21, pp. 4771-4781
2020
-
Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies
Drug Resistance Updates, Vol. 53
2019
-
Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells
OncoImmunology, Vol. 8, Núm. 7
-
Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis
Leukemia, Vol. 33, Núm. 5, pp. 1256-1267
-
Impact of prophylactic TNF blockade in the dual PD-1 and CTLA-4 immunotherapy efficacy and toxicity
Cell Stress, Vol. 3, Núm. 7, pp. 236-239
-
Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
Nature, Vol. 569, Núm. 7756, pp. 428-432
2018
-
International Symposium: Trailblazing in Cancer Immunotherapy, October 29–31, 2017, Pamplona, Spain
Cancer Immunology, Immunotherapy
2017
-
Anti-CD137 and PD-1/PD-L1 antibodies en route toward clinical synergy
Clinical Cancer Research, Vol. 23, Núm. 18, pp. 5326-5328
-
Antibody-dependent cell cytotoxicity: Immunotherapy strategies enhancing effector NK cells
Immunology and Cell Biology, Vol. 95, Núm. 4, pp. 347-355